ASH 45th (2003)

Title Content type
Continuous Intravenous Infusion Idarubicin and Busulphan as Conditioning for Elderly Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation: A Feasibility Study. Session Type: Publication Only (click for details)
MHC-Mismatched Murine Committed Myeloid Progenitors Engraft and Protect Against Invasive Aspergillosis. Session Type: Poster Session 724-III (click for details)
Characteristics and Outcome of Autoimmune Thrombocytopenic Purpura (AITP) in Patients with Common Variable Immunodeficiency (CVI): Analysis of 21 Cases. Session Type: Poster Session 180-I (click for details)
Improving Dosing Precision in Busulfan(bu)-Based Preparative Regimens for Hematopoietic Stem Cell Transplantation (HSCT). Session Type: Publication Only (click for details)
Causes of Death by Necropsy after Allogeneic Stem Cell Transplantation. Session Type: Publication Only (click for details)
Imatinib Mesylate (Glivec, STI-571) in Patients with bcr-abl-positive CML with Minimal Residual Disease Post Allogeneic SCT Is Safe and Efficacious: Results of a Phase II Open-Label Study. Session Type: Poster Session 845-II (click for details)
Acquired Factor VIII Inhibitors in Non-Hemophilic Patients: A Clinical Analysis of 15 Cases. Session Type: Publication Only (click for details)
Cidofovir for Adenovirus Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant Recipients. Session Type: Poster Session 858-III (click for details)
Causes of Death - Other Than Progressive Leukemia - in Childhood Acute Lymphoblastic (ALL) and Myeloid Leukemia (AML): The Dutch Childhood Leukemia Study Group (DCLSG) Experience. Session Type: Poster Session 500-III (click for details)
Results of a Phase II Trial (STI571-CML-Ped) Testing Imatinib (Gleevec, Glivec) in Children with Chronic Myelogenous Leukemia (CML). Session Type: Oral Session (click for details)


Subscribe to ASH 45th (2003)